Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models

Iodine-131 (131I) is one of the most frequently used radionuclides for diagnosis and therapy of thyroid diseases. It is administered orally in the treatment of cancer to eliminate the residual postoperative microscopic tumor foci, and the residual normal thyroid tissue for early detection of recurre...

Full description

Bibliographic Details
Main Authors: Mezaguer-Lekouaghet Meriem, Blanchardon Eric, Badreddine Abdelwahab, Bertho Jean-Marc, Souidi Maamar, Baz Ahcène, Lounis-Mokrani Zohra
Format: Article
Language:English
Published: EDP Sciences 2019-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2019/03/bioconf_heir2018_07004.pdf
id doaj-d37d182019c8468b907413dc99811812
record_format Article
spelling doaj-d37d182019c8468b907413dc998118122021-04-02T19:06:55ZengEDP SciencesBIO Web of Conferences2117-44582019-01-01140700410.1051/bioconf/20191407004bioconf_heir2018_07004Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat modelsMezaguer-Lekouaghet MeriemBlanchardon EricBadreddine AbdelwahabBertho Jean-MarcSouidi MaamarBaz AhcèneLounis-Mokrani ZohraIodine-131 (131I) is one of the most frequently used radionuclides for diagnosis and therapy of thyroid diseases. It is administered orally in the treatment of cancer to eliminate the residual postoperative microscopic tumor foci, and the residual normal thyroid tissue for early detection of recurrence [1]. The comparative behavior of 131I concentration into two animalmodels with total and partial thyroid has been investigated in our previous work [2]. The accumulated activities have been measured in fourteen organs. In this study, the mean absorbed doses resulting from 131I accumulated in all organs have been evaluated using RODES software [3, 4]. With this software, mean absorbed doses were calculatedfor selected organs (thyroid, lungs, heart, liver, kidneys, stomach, spleen, large and small intestine, testes, urinary bladder wall) by combining the specific absorbed fractions (SAF) of energy with radiation emission spectra and biokinetic data determined from our previous experimental study [2]. Calculations were based on the 131I photon and electron emissions reported by [5] and SAFs previously calculated by Monte Carlo simulation in the voxel phantom of an adult male rate [3, 4]. The obtained results show high absorbed dosesdeliveredto stomach and lungs for both models compared to other organs. The dose received by the testes and salivary glands is found to be higher in the case of the rat model without thyroid. Conversely, the spleen and bladder wall received lower doses in this latter model compared to those received by the rat model with thyroid. One can also note that the difference in mean absorbed dose received by liver, lungs, heart, and walls of the stomach is not significant between the two rat models.https://www.bio-conferences.org/articles/bioconf/pdf/2019/03/bioconf_heir2018_07004.pdf
collection DOAJ
language English
format Article
sources DOAJ
author Mezaguer-Lekouaghet Meriem
Blanchardon Eric
Badreddine Abdelwahab
Bertho Jean-Marc
Souidi Maamar
Baz Ahcène
Lounis-Mokrani Zohra
spellingShingle Mezaguer-Lekouaghet Meriem
Blanchardon Eric
Badreddine Abdelwahab
Bertho Jean-Marc
Souidi Maamar
Baz Ahcène
Lounis-Mokrani Zohra
Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
BIO Web of Conferences
author_facet Mezaguer-Lekouaghet Meriem
Blanchardon Eric
Badreddine Abdelwahab
Bertho Jean-Marc
Souidi Maamar
Baz Ahcène
Lounis-Mokrani Zohra
author_sort Mezaguer-Lekouaghet Meriem
title Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
title_short Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
title_full Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
title_fullStr Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
title_full_unstemmed Absorbed dose evaluation at different organs after 131I oral contamination of two Wistar rat models
title_sort absorbed dose evaluation at different organs after 131i oral contamination of two wistar rat models
publisher EDP Sciences
series BIO Web of Conferences
issn 2117-4458
publishDate 2019-01-01
description Iodine-131 (131I) is one of the most frequently used radionuclides for diagnosis and therapy of thyroid diseases. It is administered orally in the treatment of cancer to eliminate the residual postoperative microscopic tumor foci, and the residual normal thyroid tissue for early detection of recurrence [1]. The comparative behavior of 131I concentration into two animalmodels with total and partial thyroid has been investigated in our previous work [2]. The accumulated activities have been measured in fourteen organs. In this study, the mean absorbed doses resulting from 131I accumulated in all organs have been evaluated using RODES software [3, 4]. With this software, mean absorbed doses were calculatedfor selected organs (thyroid, lungs, heart, liver, kidneys, stomach, spleen, large and small intestine, testes, urinary bladder wall) by combining the specific absorbed fractions (SAF) of energy with radiation emission spectra and biokinetic data determined from our previous experimental study [2]. Calculations were based on the 131I photon and electron emissions reported by [5] and SAFs previously calculated by Monte Carlo simulation in the voxel phantom of an adult male rate [3, 4]. The obtained results show high absorbed dosesdeliveredto stomach and lungs for both models compared to other organs. The dose received by the testes and salivary glands is found to be higher in the case of the rat model without thyroid. Conversely, the spleen and bladder wall received lower doses in this latter model compared to those received by the rat model with thyroid. One can also note that the difference in mean absorbed dose received by liver, lungs, heart, and walls of the stomach is not significant between the two rat models.
url https://www.bio-conferences.org/articles/bioconf/pdf/2019/03/bioconf_heir2018_07004.pdf
work_keys_str_mv AT mezaguerlekouaghetmeriem absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT blanchardoneric absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT badreddineabdelwahab absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT berthojeanmarc absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT souidimaamar absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT bazahcene absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
AT lounismokranizohra absorbeddoseevaluationatdifferentorgansafter131ioralcontaminationoftwowistarratmodels
_version_ 1721549555511590912